This inventor holds 2 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2000-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2000-2001
Title: Innovations of Wen-Yi Gao
Introduction
Wen-Yi Gao is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of virology, particularly in the development of methods to inhibit the replication of reverse transcriptase-dependent viruses. With a total of 2 patents, his work has implications for both plant and animal cells.
Latest Patents
Wen-Yi Gao's latest patents include a procedure to block the replication of reverse transcriptase-dependent viruses. This method involves administering a compound that depletes the intracellular pool of deoxyribonucleoside phosphate, effectively inhibiting the replication of the virus. Hydroxyurea is identified as a suitable compound for this purpose. Additionally, he has developed a method for producing incomplete reverse-transcriptase dependent viral DNA by using a deoxyribonucleoside phosphate-depleting drug on infected cells.
Career Highlights
Throughout his career, Wen-Yi Gao has worked with prominent organizations, including the United States of America as represented by the Department of Health and the Department of Health and Human Services. His work has been instrumental in advancing the understanding and treatment of viral infections.
Collaborations
Wen-Yi Gao has collaborated with notable colleagues such as Franco Lori and Andrea Cara. Their combined expertise has contributed to the success of his innovative projects.
Conclusion
Wen-Yi Gao's contributions to the field of virology through his patents and collaborations highlight his role as a significant inventor. His innovative methods for inhibiting viral replication continue to impact research and development in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile